David C. Linehan, a surgical oncologist specializing in malignancies of the liver, pancreas, and biliary tract, was named CEO of the University Rochester Medical Center, dean of the School of Medicine and Dentistry, and senior vice president for health sciences.
Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient undergoes surgery, and cancer stage at diagnosis continues to be a leading factor in determining a person’s survival rate for all types of cancer, according to the first-ever annual cancer report from the National Cancer Database.
